UBS O'Connor »

Carmell Therapeutics Corp - US shares owned by UBS O'Connor

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2024-03-31 $57k 371k 0.15
2023-09-30 $91k 371k 0.25

More positions owned by UBS O'Connor

Spirit Air Note1 (Principal)
Peloton In Note2 (Principal)
Ryanair Ho Spons (RYAAY)
Revance Th Note1 (Principal)
Occidental Petroleum Corporation (OXY)
Okta Cla (OKTA)
NVIDIA Corporation (NVDA)
New Provid Class (NPAB)
Acorda The Note6 (Principal)
Bandwidth Note0 (Principal)
Screaming Class (SCRM)
Norfolk Southern (NSC)
Pentair Pl SHS (PNR)
Broadcom (AVGO)
Autoliv (ALV)

View all positions for UBS O'Connor

Top funds holding Carmell Therapeutics Corp - US

UBS O'Connor
Balyasny Asset Management
OZ Management
Millennium Management
Highbridge Capital Management
Exos Asset Management
Exos TFP Holdings
Citadel Advisors
CNH Partners
Walleye Trading Advisors
Cowen And Company
Saba Capital Management
Whitebox Advisors
Clear Street
Wolverine Asset Management

View all funds holding Carmell Therapeutics Corp - US